ALTEOGEN Future Growth

Future criteria checks 6/6

ALTEOGEN is forecast to grow earnings and revenue by 130.7% and 78.4% per annum respectively. EPS is expected to grow by 130.6% per annum. Return on equity is forecast to be 67.6% in 3 years.

Key information

130.7%

Earnings growth rate

130.6%

EPS growth rate

Biotechs earnings growth81.7%
Revenue growth rate78.4%
Future return on equity67.6%
Analyst coverage

Low

Last updated26 Nov 2024

Recent future growth updates

Recent updates

ALTEOGEN's (KOSDAQ:196170) Shareholders Should Assess Earnings With Caution

May 25
ALTEOGEN's (KOSDAQ:196170) Shareholders Should Assess Earnings With Caution

ALTEOGEN (KOSDAQ:196170) Has Debt But No Earnings; Should You Worry?

Feb 29
ALTEOGEN (KOSDAQ:196170) Has Debt But No Earnings; Should You Worry?

Earnings and Revenue Growth Forecasts

KOSDAQ:A196170 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026422,800308,700276,700297,0502
12/31/2025103,26725,03318,40017,0333
12/31/202484,50023,0008,35025,1502
9/30/202474,375-2,906-11,25321,653N/A
6/30/202490,788-1,282-17,33816,054N/A
3/31/2024121,08725,542-5,93131,966N/A
12/31/202396,523-3,372-51,203-7,766N/A
9/30/202385,0366,459-47,997-5,918N/A
6/30/202369,1547,865-54,448-10,137N/A
3/31/202332,199-21,798-65,152-17,104N/A
12/31/202228,806-8,146-60,366-17,875N/A
9/30/202232,2921,367-48,159-3,432N/A
6/30/202233,065-223-38,075-3,080N/A
3/31/202233,807-1,243-36,477-6,327N/A
12/31/202138,746-6,275-33,536-9,461N/A
9/30/202129,498-38,971-38,304-24,242N/A
6/30/202137,316-26,975-13,157600N/A
3/31/202144,433-17,748-5,171147N/A
12/31/202042,426-15,822-4,0161,512N/A
9/30/202051,93515,42414,53721,726N/A
6/30/202043,4209,040-2,9915,475N/A
3/31/202035,2425,001-1039,187N/A
12/31/201929,229-7058049,133N/A
9/30/201918,012-7,900-12,042-7,301N/A
6/30/201915,796-8,574-18,254-8,421N/A
3/31/201913,473-8,078-15,481-7,995N/A
12/31/201813,703-6,872-16,472-9,113N/A
9/30/201813,079-11,776-15,102-8,027N/A
6/30/201812,610-9,945N/A-7,065N/A
3/31/201811,788-10,332N/A-6,763N/A
12/31/201712,104-7,449N/A-4,347N/A
9/30/201711,815-2,837N/A-6,028N/A
6/30/201711,567-2,871N/A-1,809N/A
3/31/201710,569-1,961N/A-2,797N/A
12/31/20166,844-3,587N/A-3,159N/A
9/30/20166,088-1,481N/A1,869N/A
6/30/20164,213-201N/A-902N/A
3/31/20163,634-136N/A1,726N/A
12/31/20154,7271,208N/A2,264N/A
9/30/20154,585337N/A1,210N/A
6/30/20155,686320N/A2,476N/A
3/31/20156,8741,209N/A1,074N/A
12/31/20147,043931N/A1,210N/A
9/30/20146,7531,158N/A898N/A
6/30/20146,2571,224N/A-255N/A
3/31/20146,0031,434N/A1,118N/A
12/31/20135,5271,606N/A1,995N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A196170 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.7%).

Earnings vs Market: A196170 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: A196170 is expected to become profitable in the next 3 years.

Revenue vs Market: A196170's revenue (78.4% per year) is forecast to grow faster than the KR market (9% per year).

High Growth Revenue: A196170's revenue (78.4% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: A196170's Return on Equity is forecast to be very high in 3 years time (67.6%).


Discover growth companies